Nasal steroid spray for preventing ear fluid after radiation treatment
Treatments studied
Part of Ear, nose & throat, Injuries & trauma clinical trials.
This study tests whether a nasal steroid spray can help prevent fluid buildup in the middle ear (a condition that can cause hearing problems) after radiation therapy for nasopharyngeal cancer. If effective, it could help reduce hearing issues and improve your quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have been diagnosed with nasopharyngeal carcinoma and are scheduled to receive radiation therapy (with or without chemotherapy).
- You have not had radiation therapy to the head or neck before.
- Your eardrums are intact and you have not had middle ear surgery or ear tubes.
- You are willing to use a nasal spray, attend hearing tests, and return for follow-up visits for about 12 months.
- You have not used steroid pills, nasal steroid sprays, allergy pills, or decongestants in the 2 weeks before starting the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether applying a nasal ointment can reduce the risk of infections during radiation therapy for head and neck cancer. It may help patients avoid treatment delays and complications.
This trial tests whether a new form of steroid (triamcinolone) delivered in tiny capsules can improve healing after common nasal surgeries for chronic sinusitis or nasal polyps.
This trial tests whether shrinking the area that gets radiation in the nasal cavity can reduce side effects while still treating the cancer effectively. If you have nasopharyngeal cancer that has spread into your nose, this study might help lower radiation exposure to that area.
This Phase 2 study tests a new way of delivering a steroid medicine (fluticasone) through the nose to treat eustachian tube dysfunction, which can cause ear pressure, popping, or discomfort. It may help by reducing swelling around the eustachian tube so the ear can drain and equalize pressure better.
This trial tests whether giving a lower dose of radiation to the main tumor is safe and effective for people with nasopharyngeal cancer (a type of nose/throat cancer) who first receive a combination of immunotherapy (toripalimab) and chemotherapy. It aims to reduce side effects while still controlling the cancer.
This trial compares two treatments for early-stage nasopharyngeal cancer that has returned after radiation: surgery versus intensity-modulated radiation therapy (IMRT). The goal is to see which approach is more effective at controlling the cancer while keeping side effects manageable.
Hear when a new Otitis Media trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.